Similar articles

• A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.

  van As A, Benjamin C, Stern JD. van As A, et al. Scand J Respir Dis. 1973;54(1):28-37. Scand J Respir Dis. 1973. PMID: 4690403 Clinical Trial. No abstract available.
• Bronchodilator and corticosteroid effects on regional and total airway resistance in patients with asthma, chronic bronchitis, and chronic pulmonary emphysema.

  Watanabe S, Renzetti AD Jr, Bigler A. Watanabe S, et al. Am Rev Respir Dis. 1972 Sep;106(3):392-403. doi: 10.1164/arrd.1972.106.3.392. Am Rev Respir Dis. 1972. PMID: 4404156 No abstract available.
• [Effect of hexoprenaline on blood pressure].

  Lageder H, Hitzenberger G, Thoma F, Irsigler K. Lageder H, et al. Int J Clin Pharmacol. 1974 Sep;10(2):90-4. Int J Clin Pharmacol. 1974. PMID: 4448556 Clinical Trial. German. No abstract available.
• Beta-adrenergic bronchodilators.

  Avner SE. Avner SE. Pediatr Clin North Am. 1975 Feb;22(1):129-39. doi: 10.1016/s0031-3955(16)33108-x. Pediatr Clin North Am. 1975. PMID: 1096044 Review. No abstract available.
• Anticholinergic, antimuscarinic bronchodilators.

  Gross NJ, Skorodin MS. Gross NJ, et al. Am Rev Respir Dis. 1984 May;129(5):856-70. doi: 10.1164/arrd.1984.129.5.856. Am Rev Respir Dis. 1984. PMID: 6372560 Review.